Glipizide-d11
CAS: 1189426-07-0
Ref. 3D-PXB42607
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
Glipizide-d11 is a liquid chromatography-mass spectrometry (LC-MS/MS) method for the quantitative determination of glipizide in human plasma. The validation process encompasses the evaluation of the linearity, accuracy, selectivity and robustness of the method. This method has been validated to ensure that it is suitable for use by other laboratories.
Glipizide-d11 has been shown to be effective in treating diabetes mellitus type II and can be used to control blood glucose levels. It is classified as an antidiabetic agent and is used to lower blood sugar levels in patients with type II diabetes mellitus. Glipizide-d11 also has a low incidence of side effects on the heart, liver, or kidneys.
Chemical properties
Technical inquiry about: 3D-PXB42607 Glipizide-d11
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
